BA
AMRI

BlackRock Advisors’s Albany Molecular Research Inc AMRI Stock Holding History

BlackRock Advisors’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.69M Buy
250,181
+43,398
+21% +$738K ﹤0.01% 1160
2016
Q3 		$3.41M Buy
206,783
+194,401
+1,570% +$2.88M ﹤0.01% 1261
2016
Q2 		$166K Buy
12,382
+374
+3% +$5.46K ﹤0.01% 2708
2016
Q1 		$184K Buy
12,008
+958
+9% +$15K ﹤0.01% 2600
2015
Q4 		$219K Sell
11,050
-4,954
-31% -$94.1K ﹤0.01% 2521
2015
Q3 		$279K Sell
16,004
-457
-3% -$9.3K ﹤0.01% 2538
2015
Q2 		$333K Buy
16,461
+1,128
+7% +$21.8K ﹤0.01% 2473
2015
Q1 		$270K Buy
15,333
+2,200
+17% +$37.5K ﹤0.01% 2506
2014
Q4 		$214K Sell
13,133
-624
-5% -$11.5K ﹤0.01% 2588
2014
Q3 		$304K Sell
13,757
-325
-2% -$6.66K ﹤0.01% 2340
2014
Q2 		$283K Sell
14,082
-2,271
-14% -$38.5K ﹤0.01% 2420
2014
Q1 		$304K Buy
16,353
+1,257
+8% +$17.3K ﹤0.01% 2394
2013
Q4 		$152K Buy
15,096
+218
+1% +$2.63K ﹤0.01% 2830
2013
Q3 		$192K Sell
14,878
-131,968
-90% -$1.62M ﹤0.01% 2575
2013
Q2 		$1.74M Buy
+146,846
New +$1.59M ﹤0.01% 1160

Other funds holding AMRI

PIP
Permian Investment Partners Dallas, Texas $905M AUM 13.43% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Evercore Wealth Management New York $6.36B AUM 20.35% 1-Year Est. Return

BlackRock Advisors's AMRI Position: Q4 2016 in Review

BlackRock Advisors increased its Albany Molecular Research Inc (AMRI) stake by 21% in Q4 2016, buying an estimated $738K and bringing the position to 250,181 shares worth $4.69M. The position accounts for ﹤0.01% of the portfolio, ranked #1160.

BlackRock Advisors first reported a position in AMRI in Q2 2013 and has held it in 15 quarters since. 133 funds tracked by Wall St. Rank hold AMRI as of Q4 2016.

  • BlackRock Advisors held 250,181 shares of Albany Molecular Research Inc worth $4.69M as of Q4 2016.
  • BlackRock Advisors bought 43,398 Albany Molecular Research Inc shares in Q4 2016, an estimated $738K.
  • Albany Molecular Research Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1160 holding.
  • BlackRock Advisors first reported a position in Albany Molecular Research Inc in Q2 2013 and has held it in 15 quarters since.
  • 133 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.